| Group C (n = 60) | Group L (n = 60) | Group D (n = 60) | Group LD (n = 60) | P-value |
---|---|---|---|---|---|
Nausea n (%) | |||||
 0 to 2 h, n (%) | 13 (21.7%) | 8 (13.3%) | 5 (8.3%) | 3 (5.0%)* | 0.031 |
 2 to 24 h, n (%) | 25 (41.7%) | 23 (38.3%) | 19 (31.7%) | 17 (28.3%) | 0.402 |
 24 to 48 h n (%) | 5 (8.3%) | 4 (6.7%) | 3 (5.0%) | 2 (3.3%) | 0.678 |
Vomiting n (%) | |||||
 0 to 2 h, n (%) | 8 (13.3%) | 7 (11.7%) | 5 (8.3%) | 3 (5.0%) | 0.417 |
 2 to 24 h, n (%) | 18 (30.0%) | 16 (26.7%) | 15 (25.0%) | 12 (20.0%) | 0.648 |
 24 to 48 h n (%) | 2 (3.3%) | 2 (3.3%) | 1 (1.7%) | 0 (0.0%) | 0.523 |
PONV, n (%) | |||||
 0 to 2 h, n (%) | 17 (28.3%) | 12 (20.0%) | 8 (13.3%) | 5 (8.3%)* | 0.025 |
 2 to 24 h, n (%) | 30 (50.0%) | 26 (43.3%) | 23 (38.3%) | 19 (31.7%) | 0.214 |
 24 to 48 h n (%) | 5 (8.3%) | 5 (8.3%) | 3 (5.0%) | 2 (3.3%) | 0.589 |
Total 24Â h PONV, n (%) | 36 (60.0%) | 28 (46.7%) | 24 (40.0%) | 20 (33.3%)* | 0.024 |
Rescue antiemetics, n (%) | 12 (20.0%) | 10 (16.7%) | 8 (13.3%) | 5 (8.3%) | 0.311 |